Residency · Dallas, TX
Sponsored by University of Texas Southwestern Medical Center
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Lancet (London, England) · 2023 · 299 citations · Sunil Patel
AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage.
Hepatology (Baltimore, Md.) · 2024 · 149 citations · Sanjeeva Kalva
Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective.
Progress in retinal and eye research · 2021 · 368 citations · Judy Kim
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.
Ophthalmology · 2021 · 375 citations · Sunil Patel
Advances in the clinical management of uveal melanoma.
Nature reviews. Clinical oncology · 2023 · 233 citations · William Harbour
Polypoidal Choroidal Vasculopathy: Consensus Nomenclature and Non-Indocyanine Green Angiograph Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup.
Ophthalmology · 2021 · 193 citations · Judy Kim
Emerging clinical evidence of a dual role for Ang-2 and VEGF-A blockade with faricimab in retinal diseases.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025 · 52 citations · Judy Kim
Consensus and guidelines on diagnosis and management of polypoidal choroidal vasculopathy (PCV) from the Asia-Pacific Vitreo-retina Society (APVRS).
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) · 2025 · 37 citations · Judy Kim